Navigation Links
Elsevier is Expanding eClinical Solutions in Europe
Date:10/31/2008

COPENHAGEN, Denmark, October 31 /PRNewswire-FirstCall/ --

- DoctorConsult in Germany Marks First of Several Localized Workflow Solutions That Improve Clinician Decision Making and Health Care Business Performance

With a deep understanding of healthcare workflow and more than a century of experience as a global medical publisher, Elsevier is increasing its efforts to provide interactive clinical reference and clinical decision support (CDS) tools to new markets in Europe. With the launch of DoctorConsult - the German language version of MD Consult ( http://www.doctorconsult.de) -- Elsevier becomes the first multi-lingual professional clinical reference product provider.

The customized products meet the cultural needs of users who do not speak English as a first language, and address specific medical practice needs within different countries. The internet-based products provide users with a full range of medical information covering a variety of clinical needs. In one integrated interface, users can access evidence-based immediately actionable 'quick answers' (i.e. Elsevier's FirstConsult) as well as background references such as books and full text journal articles suitable for more in depth research and education needs. Additional localized versions of MD Consult are in development for Italy, France and Spain.

The Consult suite of multilingual reference products is just one of several solutions being developed to meet local reference, point-of-care, workflow and decision support needs. Additional solutions in development include:

- Clinical Decision Support:

- Guidelines and best practice information delivered when and where

they are most useful at the point of care

- Leveraging of patient data to pinpoint the most needed information

for a given clinical task

- Drug information and safety checking, also linked to patient data

when possible

- Seamless content integration with Electronic Health Records, including

infobuttons and alerts

- Payer services:

- Retrospective analytics for identifying performance gaps and outliers

- Tools to influence provider behavior (CDS solutions)

"Elsevier has been transforming CDS technology to offer a higher level of usability, primarily in the U.S. and now more so in Europe," said Jose Wehnes, Managing Director of the International Division of Elsevier Health Sciences. "Elsevier knowledge solutions, from drug information and actionable decision support, to process improvement and predictive analysis, have the potential to help deliver timely and appropriate information to clinicians in any country as they make critical diagnostic and therapeutic decisions throughout their workday."

Capturing 'e' Opportunities

Elsevier is uniquely positioned to replicate its success in the U.S. abroad. Market dynamics are different, as European E-Health markets and Elsevier's positions within them are at an earlier stage of development than in the U.S. However, key underlying market forces are similar to those in the U.S, particularly the drive to contain costs and improve outcomes, and the rapid increase in internet usage by physicians and other healthcare practitioners.

"By building upon our core strengths in leading content to provide information and workflow solutions, we can improve outcomes and efficiencies for both payers and providers on a country by country basis," said Wehnes. "Growing Elsevier Clinical Decision Support in Europe reinforces Elsevier's broader business strategy to strengthen its lead in core content, drive the transition of print materials to e-formats and deliver solutions directly into the clinical process."

Come by booth #625 at the World of Health IT Conference in Copenhagen, Denmark November 4-6, 2008 to learn more.

About Elsevier

Elsevier is a world-leading publisher of scientific, technical and medical information products and services. Working in partnership with the global science and health communities, Elsevier's 7,000 employees in over 70 offices worldwide publish more than 2,000 journals and 1,900 new books per year, in addition to offering a suite of innovative electronic products, such as ScienceDirect (http://www.sciencedirect.com/), MD Consult ( http://www.mdconsult.com/), Mosby Nursing Consult ( http://www.nursingconsult.com) Scopus (http://www.info.scopus.com/), bibliographic databases and online reference works.

Elsevier (http://www.elsevier.com/) is a global business headquartered in Amsterdam, The Netherlands and has offices worldwide. Elsevier is part of Reed Elsevier Group plc (http://www.reedelsevier.com/), a world-leading publisher and information provider. Operating in the science and medical, legal, education and business-to-business sectors, Reed Elsevier provides high-quality and flexible information solutions to users, with increasing emphasis on the Internet as a means of delivery. Reed Elsevier's ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).

Tom Reller

Director of Corp. Relations, Elsevier

+1-212-462-1912

T.Reller@Elsevier.com


'/>"/>
SOURCE Elsevier
Copyright©2008 PR Newswire.
All rights reserved

Related medicine technology :

1. Ardea Biosciences Presents Preclinical Anti-Inflammatory Data on its Lead MEK Inhibitor, RDEA119, at the ACG 2008 Annual Meeting
2. Ironwood and Collaborators Present Preclinical Data Demonstrating That Cyclic GMP Alleviates Intestinal Pain
3. Bioheart Reports Promising Results From Preclinical Study of Adipose-Derived Acute Cell Therapy
4. PEAK Surgical Announces Positive Results From Preclinical Study of PEAK PlasmaBlade(TM) Needle
5. FluoroPharma, Inc. to Report Preclinical Data on Alzheimers Disease and Prostate Cancer PET Imaging Agents
6. Teliks Proteasome Inhibitor Program Meets a Preclinical Development Milestone
7. Genaera Releases Phase 1 Data and New Preclinical Data on the CNS Function of Trodusquemine (MSI-1436) at CBI Obesity Summit
8. Micromet and Nycomed Begin Formal Preclinical Safety Studies for Antibody MT203 for Inflammatory and Autoimmune Diseases
9. Champions Biotechnology Begins Preclinical Development of Its Lead Oncology Drug Candidate
10. Tengion Scientists Publish Key Preclinical Findings Demonstrating the Benefits of Organ Regeneration Vs. Repair
11. Radius Selects First Preclinical Candidate From SARM Discovery Program for the Treatment of Muscle Loss and Other Musculoskeletal Conditions
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... June 27, 2016 Jazz Pharmaceuticals plc (Nasdaq: ... under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as ... Celator Pharmaceuticals, Inc. ("Celator"; Nasdaq: CPXX ) ... Daylight Time). As previously announced on May ... definitive merger agreement under which Jazz Pharmaceuticals has commenced ...
(Date:6/24/2016)... 2016  Collagen Matrix, Inc., ("Collagen Matrix") the ... of collagen and mineral based medical devices for ... Bill Messer has joined the company as ... the growing portfolio of oral surgery, neurosurgery, orthopaedic ... joins the Collagen Matrix executive team as an ...
(Date:6/24/2016)... , June 24, 2016 ... of the "Structural Electronics 2015-2025: Applications, Technologies, ... In-Mold Electronics, Smart Skin, ... Photovoltaics Structural electronics involves electronic ... load-bearing, protective structures, replacing dumb structures such as ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... ... First Choice Emergency Room , the largest network of independent freestanding ... of its new Mesquite-Samuell Farm facility. , “We are pleased to announce Dr. ... James M. Muzzarelli, Executive Medical Director of First Choice Emergency Room. , Dr. ...
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the benefits of ... of the latter, setting the bar too high can result in disappointment, perhaps even ... progress toward their goal. , Research from PsychTests.com reveals that behind ...
(Date:6/24/2016)... ... 2016 , ... Marcy was in a crisis. Her son James, eight, was out of control. ... and physically. , “When something upset him, he couldn’t control his emotions,” remembers Marcy. ... rocks at my other children and say he was going to kill them. If ...
(Date:6/24/2016)... ... 24, 2016 , ... Comfort Keepers® of San Diego, CA is excited to ... Recovery® program to drive cancer patients to and from their cancer treatments. Comfort ... quality of life and ongoing independence. Getting to and from medical treatments is ...
(Date:6/24/2016)... ... June 24, 2016 , ... The Haute ... Dr. Barry M. Weintraub as a prominent plastic surgeon and the network’s newest ... world, and the most handsome men, look naturally attractive. Plastic surgery should be ...
Breaking Medicine News(10 mins):